Kymera Therapeutics
Price & Volume
Stats
See more52W Range | $19.44-$59 |
Market Cap | $4B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $44.7M |
Revenue Growth (YoY) | -55.3% |
Gross Profit (12 Mos) | -$246.1M |
Diluted EPS | -$3.49 |
News
See moreYahoo Finance • 24 days ago
Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses
Yahoo Finance • last month
Why Kymera (KYMR) Could Be One of Biotech’s Most Interesting Growth Stories?
Yahoo Finance • last month
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary
Yahoo Finance • last month
Wednesday's ETF with Unusual Volume: FYC
About
CEO | Dr. Nello Mainolfi M.D., Ph.D. |
Address | 500 North Beacon Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |
